Azuay Patients Say IESS Medicine Gaps Are Putting MS Treatment At Risk

Patients with multiple sclerosis in Azuay are pushing the IESS medicine shortage into public view after a July 3 protest in Parque Calderon.

The group says delays in IESS treatment delivery have already worsened the condition of several patients. For people who depend on biological medicine every six months, this is not an annoying paperwork delay. It can mean relapse, mobility loss, private medical bills, and months of uncertainty.

Why This Matters

One patient described a treatment that costs about $6,000 per dose, or $12,000 per year. That is the kind of number that moves a health-system issue from abstract to immediate.

The patient association Apemede sent a letter to President Daniel Noboa in early July asking for intervention so treatments continue for more than 400 affected families.

Patients also say the problem is not only medicine. Gabriela Toral, representing patients, said people with the disease are also having trouble getting control exams.

The Practical Part

One patient said periodic MRI scans cannot be done through IESS because the machines are damaged, forcing patients to private centers where each study costs $200 to $300.

The local concern is bigger than one appointment or one shipment. The same report says there are around 100 people in the Austro diagnosed with multiple sclerosis, and some patients have gone up to a year without medication.

For expats who rely on IESS, this is worth watching closely. It is a reminder that public coverage and actual access are not always the same thing.